Jorge Quintana, MD
Psychiatry · Rahway, NJNPI 1326103128
Payments from drug & device makers
Across 1,228 payments — averaging $13.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Neurocrine Biosciences, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Sunovion Pharmaceuticals Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Axsome Therapeutics, Inc.$925
- plus $7K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 216 | $2,614 |
| Neurocrine Biosciences, Inc. | 101 | $2,024 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 116 | $1,856 |
| Sunovion Pharmaceuticals Inc. | 101 | $1,157 |
| Otsuka America Pharmaceutical, Inc. | 110 | $1,086 |
| Axsome Therapeutics, Inc. | 57 | $925 |
| Teva Pharmaceuticals USA, Inc. | 75 | $849 |
| Lundbeck LLC | 67 | $818 |
| Alkermes, Inc. | 33 | $705 |
| Takeda Pharmaceuticals U.S.A., Inc. | 53 | $686 |
| Bausch Health US, LLC | 45 | $507 |
| Jazz Pharmaceuticals Inc. | 27 | $478 |
| Vanda Pharmaceuticals Inc. | 38 | $448 |
| Almatica Pharma LLC | 30 | $424 |
| Corium, LLC | 35 | $397 |
| Idorsia Pharmaceuticals US Inc | 24 | $311 |
| Tris Pharma Inc | 21 | $309 |
| Supernus Pharmaceuticals, Inc. | 11 | $293 |
| Johnson & Johnson | 13 | $192 |
| Harmony Biosciences LLC | 2 | $137 |
| Avanir Pharmaceuticals, Inc. | 8 | $117 |
| Noven Therapeutics, LLC | 8 | $112 |
| E.r. Squibb & Sons, L.L.C. | 5 | $87 |
| Alfasigma USA, Inc. | 6 | $75 |
| Arbor Pharmaceuticals, Inc. | 5 | $72 |
| Merck | 5 | $69 |
| Eisai Inc. | 5 | $65 |
| Luye Pharma (USA) Ltd. | 3 | $47 |
| Neos Therapeutics, LP | 2 | $26 |
| Adlon Therapeutics L.p. | 2 | $26 |
| Shire North American Group Inc | 2 | $24 |
| Braeburn Inc. | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
How this compares
$16,966 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Rahway
- Leon RosenbergCherry Hill$6.4M
- Steven GlassClementon$3.9M
- Judith JosephPaterson$3.8M
- Jeffrey ApterPrinceton$1.7M
- Roberta BallCherry Hill$741K
- Marc CantillonLivingston$524K
- Sanjay VarmaPrinceton$479K
- Manuel SanchezNewark$474K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.